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Abstract
Background: The mechanism of cardiac energy production against sustained pressure overload remains to be elucidated.
Methods and Results: We generated cardiac-specific kinase-dead (kd) calcium/calmodulin-dependent protein kinase
kinase-b (CaMKKb) transgenic (a-MHC CaMKKbkd TG) mice using a-myosin heavy chain (a-MHC) promoter. Although
CaMKKb activity was significantly reduced, these mice had normal cardiac function and morphology at baseline. Here, we
show that transverse aortic binding (TAC) in a-MHC CaMKKbkd TG mice led to accelerated death and left ventricular (LV)
dilatation and dysfunction, which was accompanied by significant clinical signs of heart failure. CaMKKb downstream
signaling molecules, including adenosine monophosphate-activated protein kinase (AMPK), were also suppressed in a-MHC
CaMKKbkd TG mice compared with wild-type (WT) mice. The expression levels of peroxisome proliferator-activated receptor-
c coactivator (PGC)-1a, which is a downstream target of both of CaMKKb and calcium/calmodulin kinases, were also
significantly reduced in a-MHC CaMKKbkd TG mice compared with WT mice after TAC. In accordance with these findings,
mitochondrial morphogenesis was damaged and creatine phosphate/b-ATP ratios assessed by magnetic resonance
spectroscopy were suppressed in a-MHC CaMKKbkd TG mice compared with WT mice after TAC.
Conclusions: These data indicate that CaMKKb exerts protective effects on cardiac adaptive energy pooling against
pressure-overload possibly through phosphorylation of AMPK and by upregulation of PGC-1a. Thus, CaMKKb may be a
therapeutic target for the treatment of heart failure.
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Introduction
Previous studies determined that a calcium (Ca2+)-mediated
signaling cascade resulting from mechanical overload or Gq-
mediated signaling initiates changes that lead to cardiac hyper-
trophy through the activation of calcineurin and consequent
targeting of nuclear factor of activated T-cells (NFAT) transcrip-
tion factors. Ca2+/calmodulin kinase (CaMK) II activation and
subsequent NFAT3 signaling act in concert to promote pathologic
hypertrophic signaling and cardiac growth. However, there is a
lack of knowledge whether there is a signaling mechanism to
compensate for cardiac energy production against sustained
pressure load.
Numerous hormones, growth factors, and physiological pro-
cesses cause a rise in cytosolic Ca2+ concentration, which is
translated into cellular responses by interacting with a large
number of Ca2+-binding proteins [1]. The Ca2+-binding protein
that is most pervasive in mediating these responses is calmodulin
(CaM), which acts as a primary receptor for Ca2+ in all eukaryotic
cells [2]. Upon Ca2+ binding, CaM increases its affinity for a large
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number of CaM-binding proteins, including three multifunctional
CaM kinases (CaMKs; CaMKI, CaMKII, and CaMKIV). CaMK
kinases (CaMKKs) initiate the signaling cascade by phosphoryla-
tion and activation of two CaMKs, CaMKI and CaMKIV,
whereas CaMKII can be activated by Ca2+/CaM without the
activation of CaMKK [3]. Two CaMKK genes (CaMKKa and
CaMKKb) have been identified in mammals, both of which are
strongly expressed in the brain [4,5]. For full activation, CaMKI
and CaMKIV require phosphorylation on an activation loop Thr
by CaMKKa or CaMKKb. In addition to its role in these
enzymatic cascades, CaMKKb is also a physiologically relevant
upstream activator of adenosine monophosphate (AMP)-activated
protein kinase (AMPK); this CaMKKb-AMPK complex is known
to regulate the energy balance by acting in the hypothalamus [6].
We demonstrated previously that CaMKKb is important for
GLUT4 translocation through AMPK activation in cardiomyo-
cytes [7]. Moreover, CaMKKb was shown to be important for
mitochondrial biogenesis and exercise tolerance through its
downstream target of peroxisome proliferator-activated receptor-
c coactivator (PGC)-1a by the use of muscle-specific adiponectin-
deficient mice [8]. Therefore, it is possible that CaMKKb in the
heart exerts its role to compensate cardiac energy production
against Ca2+ overload induced by sustained pressure load.
In this study, we focused on CaMKKb in the control of cardiac
function after transverse aortic constriction (TAC). We generated
cardiac-specific kinase-dead (kd) CaMKKb (CaMKKbkd) trans-
genic (TG) mice, using an a-myosin heavy chain (a-MHC)
promoter to define the structural and functional responses of the




Male C57BL/6 mice were purchased from Japan SLC inc.
(Shizuoka, Japan) and maintained in a specific pathogen-free
facility. The a-MHC promoter drives transgene expression
exclusively in cardiac myocytes and has been used extensively in
transgenic studies. A kd form of CaMKKb harboring a mutation
of aspartic acid residue 329 to alanine had no effect on its
downstream kinases [9] was utilized in our previous experiments
[7]. To generate a-MHC CaMKKbkd TG mice, we placed an a-
MHC promoter and FLAG tag at the 59 end of a kd form of
CaMKKb. Transgenic DNA was microinjected into zygotes using
a standard methodology, as described previously [10]. Transgenic
mice and non-transgenic littermates as controls were maintained
on a 12-h light/dark cycle, fed a normal laboratory diet ad libitum,
sacrificed by decapitation under ether anesthesia at the indicated
age and analyzed. This investigation conformed to the Guide for
the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85-23, revised
1996). All animal care, experiments, and methods were approved
by the Animal Care and Use Committees of Kyoto University
Graduate School of Medicine. We determined humane endpoints
beforehand for the survival study. The criteria used to determine
when the animals should be humanely sacrificed is rapid or
progressive weight loss of more than 20% of the body weight,
dehydration determined by an increase in skin tenting, sunken
eyes, respiratory symptoms such as labored breathing, nasal
discharge, coughing, or cyanosis. The animals were carefully
monitored three times a day.
2. Surgery
Constriction of the transverse thoracic aorta was performed on
3-month-old mice as described previously [11]. In brief, mice were
anesthetized, intubated, and placed on a respirator. Midline
sternotomy was performed, the aorta was visualized, and a 6.0
prolene suture was placed around the aorta distal to the
brachiocephalic artery. The suture was tightened around a blunt
26-gauge needle placed adjacent to the aorta. The needle was then
removed, and the chest and overlying skin were closed. Sham-
operated mice underwent a similar operation in which the aortic
arch was isolated and a band was tightened around the aorta but
not ligated and was removed subsequently.
3. Transthoracic echocardiography
Echocardiography was performed as described previously [12].
Briefly, mice were anesthetized using an intraperitoneal injection
of 2-2-2 tribromoethanol (240 mg/kg, Wako Pure Chemical
Industries, Osaka, Japan), and transthoracic echocardiography
was performed using a Sonos-5500 echocardiograph (Agilent
Technologies, Santa Clara, CA) with a 15-MHz linear transducer.
M-mode echocardiograms were obtained at the papillary muscle
level. At least two independent M-mode measurements per animal
were carried out by an examiner blinded to the genotype of the
animals. Fractional shortening was calculated as (LVIDd–LVIDs)/
LVIDd*100.
4. Histological analysis
After anesthesia, we injected 0.1 mL of 1% CdCl2 via inferior
vena cava to achieve diastolic arrest. Then we perfused and fixed
mice with 4% paraformaldehyde at 30 cm H2O before excising
the heart, which was further fixed in 4% paraformaldehyde at 4uC
overnight. Paraffin sections were stained with Masson trichrome
and Sirius red staining. All photos were taken using a BZ-9000
microscope (Keyence, Osaka, Japan).
5. Transmission electron microscopy
Left ventricular (LV) cardiac tissue was quickly cut into 1 mm
cubes, immersion-fixed with 2.5% glutaraldehyde in 0.1 mol/L
phosphate buffer (pH 7.4) overnight at 4uC, and postfixed in 1%
buffered osmium tetroxide. The specimens were then dehydrated
through a graded ethanol series and embedded in epoxy resin.
Ultrathin sections (90 nm), double-stained with uranyl acetate and
lead citrate, were examined using an electron microscope (H-800,
Hitachi, Tokyo, Japan).
6. Mitochondrial DNA analysis
The amount of mitochondrial DNA was quantified using
quantitative PCR as described previously [13]. Total DNA was
isolated using a QIAmp DNA microkit (Qiagen, Venlo, Nether-
lands). The levels of cytochrome b (Cytb), NADH dehydrogenase
subunit 1 (Nd1), and cytochrome c oxidase 1 (Co1) genes in the
mtDNA genome were quantified. Results were normalized to the
nuclear housekeeping gene H19. The delta-delta Ct method was
used for quantification. Primer sequences are indicated in Table
S1.
7. Measurement of superoxide
Superoxide levels were measured using a superoxide-sensitive
dye, dihydroethidine (DHE). DHE is cell permeable and, in the
presence of superoxide, is converted to fluorescent ethidium
bromide (EtBR), which is trapped by intercalating with DNA.
5 mM DHE (Sigma-Aldrich, St. Louis, MO) was applied to heart
cross-sections (7 mm) and incubated in a light-protected and
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humidified chamber at 37uC for 30 min. In situ fluorescence was
assessed using fluorescence microscopy.
8. Western blotting
Total protein was extracted from frozen hearts, resolved and
subjected to sodium dodecylsulfate polyacrylamide gel electropho-
resis (SDS-PAGE) followed by standard Western blotting proce-
dures [7]. A total of 20 mg protein was fractionated using
NuPAGE 4–12% Bis-Tris (Invitrogen) gels and transferred to a
Protran nitrocellulose transfer membrane (Whatman). The anti-
bodies used for Western blotting were as follows: anti-CaMKKb
(H-95) (Santa Cruz Biotechnology, Dallas, TX, USA), 1:500; anti-
total-CaMKI (sc-33165) (Santa Cruz Biotechnology), 1:1000; anti-
phospho-CaMKIV (sc-28443-R) (Santa Cruz Biotechnology),
1:500; anti-total-CaMKIV (sc-55501) (Santa Cruz Biotechnology),
1:1000; anti-phospho-AMPKa (Cell Signaling Technology, Bev-
erly, MA, USA), 1:500; anti-total-AMPKa (Cell Signaling
Technology), 1:1000; and anti-GAPDH (Cell Signaling Technol-
ogy), 1:2000. Anti-phospho-CaMKI (Thr177) was a kind gift from
Figure 1. Generation of a-MHC CaMKKbkd TG mice. A. Immunoblotting and densitometry for calcium/calmodulin-dependent protein kinase
kinase-b (CaMKKb) after transverse aortic binding (TAC) in wild-type (WT) mice. Values are the means 6 standard error (S.E.) of four independent
experiments (*p,0.05 vs 0 week). B. Immunoblotting for CaMKKb in WT mice and two lines of a-MHC CaMKKbkd TG mice. C. Immunoblotting for flag
tag in two lines of a-MHC CaMKKbkd TG mice indicating the heart-specific overexpression of the transgene. D. Activities of CaMKKb in the hearts of
two lines of a-MHC CaMKKbkd TG mice by immunoprecipitate kinase assays.
doi:10.1371/journal.pone.0108201.g001
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Dr. Naohito Nozaki (Kanagawa Dental College, Yokosuka,
Kanagawa, Japan) and used at the dilution of 1:50. Anti-rabbit
IgG (GE Healthcare) and anti-mouse IgG (GE Healthcare) were
used as secondary antibodies at a dilution of 1:2000.
9. CaMKKb activity
Heart tissues were rapidly frozen in liquid nitrogen. The frozen
tissue was ground and resuspended in 100 mL homogenization
buffer (50 mM Tris/HCl, 0.25 nM mannitol, 50 mM NaF, 5 mM
Figure 2. Kaplan-Meier plot of cardiac failure-free fraction and cardiac function of WT and a-MHC CaMKKbkd TG mice after TAC. A.
a-MHC CaMKKbkd TG mice had a lower cardiac failure-free fraction compared with WT mice. Log-rank test indicates the significant difference between
WT and a-MHC CaMKKbkd TG mice after TAC (p = 0.0002) (WT; n = 26, TG; n = 25). B. Representative echocardiograph pictures of WT and a-MHC
CaMKKbkd TG hearts 3 weeks after TAC. Arrows indicate left ventricular cavities of diastolic and systolic phase. C. Serial changes in echocardiographic
parameters of WT and a-MHC CaMKKbkd TG mice after TAC. *p,0.05 vs WT (n = 3–5 for each group).
doi:10.1371/journal.pone.0108201.g002
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sodium pyrophosphate, 150 mM NaCl, 5 mg/mL soybean trypsin
inhibitor, 0.1 mM PMSF, 1% (v/v) Triton X-100) per 20 mg of
tissue and further homogenized using a hand-held motor driven
pestle. The samples were left on ice for 30 min, and then cell
debris was pelleted by centrifugation. The supernatants were
removed and protein concentrations were determined. CaMKKb
was immunoprecipitated from 500 mg of protein for 2 h at 4uC
with 10 ml of anti CaMKKb antibody (H-95, Santa Cruz
Biotechnology). The immunoprecipitates were washed and then
resuspended in kinase buffer containing 25 mM ATP and 5 mCi of
[c-32P]ATP in the presence of 1 mM calcium and plus 1 mM
calmodulin and 0.5 mg of purified recombinant human CAMKI
(P01, Abnova Corporation, Taipei, Taiwan) was added and
incubated on an orbital shaker at 37uC for 45 min. The reactions
Figure 3. Left ventricular dilatation, hypertrophy, and fibrosis is prominent in a-MHC CaMKKbkd TG mice compared with WT mice
after TAC. A. Low-power magnifications of Masson Trichrome stained images of the left ventricle of WT and a-MHC CaMKKbkd TG mice with or
without TAC. B. Heart weight (HW) and lung weight (LW) of WT and a-MHC CaMKKbkd TG mice with or without TAC. Each value was normalized to
tibial length (TL). Values are the means 6 S.E. of 5 mice (*p,0.05 vs sham control, {p,0.05 vs WT after TAC). C. Relative expression levels of
hypertrophy-associated genes in WT and a-MHC CaMKKbkd TG mice with or without TAC. Values are the means6 S.E. of four mice (*p,0.05 vs sham
control, {p,0.05 vs WT after TAC). D. Picrosirius staining of the left ventricle in WT and a-MHC CaMKKbkd TG mice with or without TAC and
measurement the area of fibrosis. Values are the means 6 S.E. of three to five mice (*p,0.05 vs sham control, {p,0.05 vs WT after TAC).
doi:10.1371/journal.pone.0108201.g003
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were stopped by addition of sample loading dye. The reaction
mixtures were separated by SDS-PAGE and exposed to X-ray film
after drying the gel. Total immunoprecipitated CaMKKb protein
were analyzed individually by Western blotting.
10. Quantitative real-time (q-RT) PCR for mRNA
Total RNA was isolated using TRIzol reagent (Invitrogen,
Carlsbad, CA). cDNA was synthesized using SuperScript II
reverse transcriptase (Invitrogen) and the PCR reaction was
performed using SYBR Green PCR master mix (Applied
Biosystems, Foster, CA), normalized with GAPDH. Gene-specific
primer sequences are indicated in Table S1.
11. Magnetic resonance imaging protocol
Magnetic resonance (MR) imaging experiments were performed
as described previously [14]. Briefly, experiments were carried out
using a Bruker Biospec MRI/MRS spectrometer (Ettlingen,
Germany) equipped with a 7-T/20-cm Oxford magnet and a
12-cm (inner diameter) actively shielded gradient set, as described
previously. In vivo MRI/MRS studies were carried out on wild-
type (WT) and TG mice before and after TAC. Anesthesia was
induced with ,1% isoflurane, as described previously. The probe
set was a 20-mm 1H/31P MRS coil. Metabolite areas were
determined from the integrated peak areas of the creatine
phosphate (PCr) and [b-P]ATP resonances from voxels centered
on cardiac muscle as identified by high-resolution MR imaging.
12. Statistics
Data are presented as means 6 standard error (SE). Statistical
comparisons were performed using unpaired two-tailed Student’s
t-tests or one-way analysis of variance with Bonferonni’s post hoc
test where appropriate. We sat the level for statistical significance
at a p,0.05.
Results
1. CaMKKb expression is upregulated by TAC
It is known that mechanical overload evokes a Ca2+-mediated
signaling cascade in the heart. Moreover, CaMKK is activated by
the elevation of intracellular Ca2+ and it may transduce important
signals during cardiac hypertrophy. Thus, we first examined the
expression of CaMKKb in the course of cardiac hypertrophy
induced by TAC. We found that the mRNA and protein levels of
CaMKKb were significantly increased 1 week after TAC and
continued to increase gradually thereafter (Fig. 1A).
2. Generation of a-MHC CaMKKbkd TG mice
To study the impact of CaMKKb expression on pressure-
loaded heart failure, we generated a-MHC CaMKKbkd TG mice.
A catalytically inactive mutant of CaMKKb was made by
mutating aspartic acid 329 to alanine (D329A) [7,9,15]. The
cardiomyocyte-specific a-MHC promoter has a transient burst of
activity in embryonic hearts between embryonic day 9.5 and 10.5,
and its activity is reactivated during early postnatal life and
remains persistently high into adulthood [16]. We obtained three
independent transgenic lines. The results from two lines are shown
in Fig. 1. Western blotting using anti-FLAG and anti-CaMKKb
antibodies confirmed cardiac overexpression and the levels of
CaMKKbkd transgenes in a-MHC CaMKKbkd TG mice (Fig. 1B
and C). We also determined the activities of CaMKKb in the
hearts of these mice using immunoprecipitate kinase assays
(Fig. 1D). CaMKKb activity was significantly suppressed in the
two lines of a-MHC CaMKKbkd TG mice. These transgenic mice
appeared to have normal cardiac development and life span
(survival of over 12 months). There was no change in body weight,
systolic blood pressure, or heart rate in intermediate and high
expression lines of a-MHC CAMKKbkd TG mice.
3. a-MHC CaMKKbkd TG mice had higher mortality
compared with WT mice
Three-month-old a-MHC CaMKKbkd TG lines and WT
control mice underwent TAC and were followed over the next 8
weeks. According to the humane endpoint rules, mice subjected to
TAC had to be sacrificed when the criteria of endpoints were
reached. Using such criteria, Kaplan-Meier analysis demonstrated
that a-MHC CaMKKbkd TG mice were significantly more likely
to develop this degree after TAC than WT control mice (Fig. 2A).
To determine the functional aspects of a-MHC CaMKKbkd TG
hearts, we used an echocardiograph to analyze cardiac structure
and function after TAC. Fig. 2B shows representative results of
echocardiography of the heart of WT mice and the high
expression line of a-MHC CaMKKbkd TG mice at 3 weeks after
Figure 4. Phosphorylation of downstream targets of CaMKKb in WT and a-MHC CaMKKbkd TG mice with or without TAC.
Representative pictures of immunoblotting for phosphorylated form and total amount of adenosine monophosphate (AMP)-activated protein kinase
(AMPK), calcium/calmodulin-dependent protein kinase (CaMK) I, and CaMKIV (A–C). Results of densitometric analysis are indicated. Values are the
means 6 S.E. of five mice (*p,0.05 vs sham control, {p,0.05 vs WT after TAC).
doi:10.1371/journal.pone.0108201.g004
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TAC. The other line of TG mice showed the same results. Fig. 2C
demonstrates that a-MHC CaMKKbkd TG mice had a significant
increase in LV end diastolic diameter (LVDd) and LV systolic
diameter (LVDs), accompanied by a reduction in contraction
Figure 5. Mitochondrial ultrastructure, DNA abundance, and metabolism-related gene expression levels in WT and a-MHC
CaMKKbkd TG mice with or without TAC. A. Relative mRNA expression levels related to mitochondrial function and biogenesis. Values are the
means 6 S.E. of six mice (*p,0.05 vs sham control, {p,0.05 vs WT after TAC). B. Abnormal mitochondrial ultrastructure in a-MHC CaMKKbkd TG
hearts after TAC. C. The amount of mitochondrial DNA quantified by quantitative PCR. Cytochrome b (Cytb), NADH dehydrogenase subunit 1 (Nd1)
and cytochrome c oxidase 1 (Co1) expression levels relative to nuclear DNA in the ventricles of WT and a-MHC CaMKKbkd TG mice with or without
TAC are shown. Values are the means6 S.E. of three to four mice (*p,0.05 vs sham control, {p,0.05 vs WT after TAC). D. Superoxide levels detected
using a superoxide-sensitive dye, dihydroethidine (DHE). Representative pictures are shown on the left. Relative intensities are shown on the right.
Values are the means 6 S.E. of three to six mice (*p,0.05 vs sham control, {p,0.05 vs WT after TAC).
doi:10.1371/journal.pone.0108201.g005
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measured as fractional shortening (FS). Further experiments were
carried on the high expression line. Fig. 3A contains low-power
magnifications of Masson trichrome staining of the heart, which
confirmed that marked dilatation occurred in the hearts of a-
MHC CaMKKbkd TG mice subjected to TAC compared with
both WT TAC hearts and a-MHC CaMKKbkd TG hearts
without TAC. Hearts from WT mice subjected to TAC were
enlarged and their weight increased twofold compared with those
from WT mice without TAC (Fig. 3B), which was consistent with
cardiac hypertrophy. In contrast, hearts from a-MHC
CaMKKbkd TG mice almost tripled in weight compared with
those from a-MHC CaMKKbkd TG mice without TAC (Fig. 3B)
and the lungs in a-MHC CaMKKbkd TG mice also increased in
weight, probably resulting from extreme congestion, compared
with those in WT TAC mice. mRNA expression levels of both
atrial and B-type natriuretic factor (Nppa and Nppb), heavy chain
of b myosin (Myh7), and a1 actin (Acta1), which are markers of
cardiac hypertrophy and failure, were increased significantly in
WT mice after TAC compared with mice without TAC and in a-
MHC CaMKKbkd TG mice after TAC compared with WT mice
Figure 6. Myocardial energy reserve measured by in situ 31P magnetic resonance (MR) spectroscopy. A. A 1H MR image to define the
region of interest to measure a 31P MR spectrum of the left ventricular anterior wall. B. In vivo cardiac 31P MR spectra from WT and a-MHC CaMKKbkd
TG mice 3 weeks after TAC. C. The creatine phosphate/ATP ratio of the left ventricle in WT and a-MHC CaMKKbkd TG after TAC. Values are
mean6standard error of the mean. *p,0.05 vs WT at same time point, n = 3–8 for each group.
doi:10.1371/journal.pone.0108201.g006
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after TAC (Fig. 3C). Picrosirius staining indicated that interstitial
fibrosis increased significantly in WT mice after TAC compared
with mice without TAC, and the levels increased significantly in a-
MHC CaMKKbkd TG mice after TAC compared with WT mice
after TAC (Fig. 3D).
4. Altered CaMKKb-mediated signaling in a-MHC
CaMKKbkd TG hearts after TAC
Next, we measured the phosphorylation levels of the AMPK,
CaMKI, and CaMKIV, which are well-established CAMKKb
downstream targets, in the hearts of WT and a-MHC CaMKKbkd
TG mice after sham surgery or TAC. Figs. 4A to C show the
results of Western blotting and densitometry analysis of the blots.
The phosphorylation levels increased significantly in WT hearts
after TAC except for CaMKI; however, the phosphorylation levels
of AMPK, CaMKI, and CaMKIV were significantly reduced in a-
MHC CaMKKbkd TG hearts compared with the WT mice after
TAC.
5. Abnormal morphology of mitochondria and
mitochondrial gene expression in a-MHC CaMKKbkd TG
hearts after TAC
The expression of PGC-1a has been reported to be modulated
in several physiological contexts by increased Ca2+ signaling via
molecules such as CaMK and CREB [17] and by CaMKKb [8].
Therefore, we measured PGC-1a expression levels in the left
ventricles of WT and a-MHC CaMKKbkd TG mice with or
without TAC. As shown in Fig. 5A, PGC1a expression levels were
the same in sham-operated WT and a-MHC CaMKKbkd TG
mice; however, its expression was significantly reduced in a-MHC
CaMKKbkd TG hearts compared with WT mice after TAC.
Pparg, Esrrsa, and Nrf1 gene expression levels were significantly
reduced in a-MHC CaMKKbkd TG hearts compared with WT
mice after TAC. We further measured ATPa5c1, Cox5c, and
Cox7a gene expression levels. These levels also showed the same
pattern as those of PGC1a. We then observed changes in
mitochondrial morphology using electron microscopy. As shown
in Fig. 5B, the mitochondria of a-MHC CaMKKbkd TG mice
were the same as those of WT mice before TAC; however, the size
of mitochondria in a-MHC CaMKKbkd TG mice became smaller
than those of WT mice after 3 weeks’ TAC. We then measured the
amount of mitochondrial DNA by PCR analysis of Cytb, Nd1, and
Co1 genes. Fig. 5C indicates that the levels of these genes were
significantly decreased after TAC in both WT and a-MHC
CaMKKbkd TG mice compared with those mice before TAC, and
the levels were further decreased after TAC in a-MHC
CaMKKbkd TG mice compared with WT mice after TAC.
Then, we measured superoxide levels using the superoxide-
sensitive dye DHE. The density of DHE increased in WT hearts
after TAC; however, such an increase was not observed in a-
MHC CaMKKbkd TG hearts after TAC compared with that
before TAC. All of these data show an abnormality in
mitochondria-related gene expression patterns and their function
in a-MHC CaMKKbkd TG hearts after TAC.
6. Impaired energetics and ATP depletion in a-MHC
CaMKKbkd TG hearts after TAC
We further tried to measure the changes in energy levels in the
hearts of WT and a-MHC CaMKKbkd TG mice in response to
pressure load. 31P MR spectrometry offers a unique means to
noninvasively quantify the major cardiac high-energy phosphates
PCr and ATP, which are critical for normal myocardial contractile
function and viability. We used 31P MR spectrometry to quantify
the in vivo PCr-to-ATP ratio (PCr/ATP) of murine hearts.
Fig. 6A shows a 1H MR image to define the region of interest
to measure the 31P MR spectrum of the LV anterior wall.
Representative cardiac 31P MR spectra from mice are shown in
Fig. 6B. As shown in Fig. 6C, the PCr/ATP ratio of a-MHC
CaMKKbkd TG mice was the same as that of WT before TAC.
The mean in vivo myocardial PCr/ATP ratios were 2.0560.04
and 1.8860.08, respectively, which were consistent with previous
reports [18]. TAC significantly reduced mean PCr/ATP ratio to
1.5860.08 in WT mice; however, the level was significantly lower
in a-MHC CaMKKbkd TG mice (1.2460.06) as early as 1 week
after TAC compared with that of WT mice. The difference
between WT and a-MHC CaMKKbkd TG mice remained
unchanged until 3 weeks after TAC.
Discussion
We have reported previously that CaMKKb can activate
AMPK in cardiomyocytes and is involved in GLUT4 transloca-
tion, based on the finding that the CaMKK inhibitor STO-609, as
well as overexpression of the dominant-negative form of
CaMKKb, inhibited its H2O2-mediated translocation [7]. It was
also suggested that H2O2-mediated increase in the intracellular
Ca2+ concentration is most likely to play a more important role
than increase in AMP:ATP ratio in AMPK activation [19]. In this
experiment, we tried to find out the mechanism of cardiac energy
production against sustained pressure overload by the use of a-
MHC CaMKKbkd TG mice, because the Ca2+-mediated signaling
cascade is important in this situation. The major findings of this
study are as follows: (1) CaMKKb expression was increased in the
left ventricle in response to pressure-overload stress by TAC in
WT mice; (2) TAC in a-MHC CaMKKbkd TG mice resulted in a
significant inhibition of CaMKKb downstream signaling mole-
cules, including AMPK, compared with those in WT mice and led
to accelerated cardiac dysfunction, which was accompanied by
signs of significant clinical heart failure and death; and (3) the
expression levels of PGC-1a, which is a downstream target of both
of CaMKKb and CaMKs, were also significantly reduced in a-
MHC CaMKKbkd TG mice compared with WT mice after TAC.
In accordance with these findings mitochondrial morphogenesis
was damaged and PCr/b-ATP ratios assessed by MR spectros-
copy were also suppressed in a-MHC CaMKKbkd TG mice
compared with WT mice after TAC. To the best of our
knowledge, these findings provide the first evidence that
CaMKKb exerts an effect on cardiac adaptive energy pooling
against pressure-overload-induced ventricular dysfunction.
Heart failure is a multifactorial, progressive, and disabling
syndrome leading to a deterioration of the heart characterized by a
symptoms resulting from ventricular dysfunction. Contractile
dysfunction is often linked to chronic energy deficit. The increased
wall stress of the ventricle enhances local oxygen consumption and
worsens the energy deficiency and function. As a consequence, the
heart enters a vicious cycle. In this context, alternative therapies
that could improve the energetic state and disrupt the vicious cycle
of the failing heart are of particular interest.
We hypothesized that there may be a signaling mechanism to
compensate cardiac energy production against sustained pressure
load. Previous studies explain that the Ca2+-mediated signaling
cascade induced by mechanical overload or Gq-mediated
signaling initiates the changes that lead to cardiac hypertrophy
[20]. CaMKKb may be one such molecule that links Ca2+
signaling and cardiac metabolism, because it is involved in
regulating many important physiological processes, including
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energy balance, adiposity, glucose homeostasis, and hematopoiesis
[21].
Our results indicated that phosphorylation of AMPK, CaMKI,
and CaMKIV was reduced in a-MHC CaMKKbkd TG mice
compared with WT mice after TAC. AMPK plays an important
role in regulating energy balance, protein synthesis, and cell
growth. AMPK activation enhances fatty acid and glucose
metabolism to augment ATP production and attenuates protein
synthesis to preserve ATP. We indicated previously that AMPK is
important for oxidative stress-mediated GLUT4 translocation in
cardiomyocytes [7]. This pathway may be enhanced under
mechanical overload with the elevation of oxidative stress [22].
Moreover, because the energy substrate switches from fatty acids
to glucose under cardiac hypertrophy/heart failure [23,24,25], the
reduction in AMPK phosphorylation may have negatively affected
energy supply in a-MHC CaMKKbkd TG mice compared with
WT mice after TAC. This may be one of the reasons why PCr/b-
ATP ratios assessed by MR spectroscopy were suppressed in a-
MHC CaMKKbkd TG mice compared with WT mice after TAC.
Previously, Zhang et al. reported that TAC resulted in more
hypertrophy and fibrosis in AMPKa2-deficient hearts than in WT
hearts, with a greater increase in LV diameter at end systole and a
greater decrease in LV ejection fraction [26]. Although there is a
difference in LV phenotype between the study by Zhang et al. and
the present study, it may be simply because other downstream
target of CaMKKb such as CaMKI and CaMKIV affected LV
structure and function in this experiment.
The expression of PGC-1a has been reported to be modulated
in several physiological contexts, for example, in skeletal muscle in
response to exercise partly by increased Ca2+ signaling via
molecules such as CaMK and CREB [17]. A recent study
indicated that quiescent and noradrenaline-exposed CaMKKb-
null hepatocytes express less mRNA encoding PGC-1a compared
with WT hepatocytes [27]. In line with these findings, CaMKKb
was shown to be important for mitochondrial biogenesis and
exercise tolerance through the activation of its downstream target
PGC-1a by the use of muscle-specific adiponectin-deficient mice
[8]. Therefore, we measured PGC-1a levels and found that its
level was significantly reduced in a-MHC CaMKKbkd TG mice
compared with WT mice after TAC. Not only PGC-1a, but other
mitochondrial biogenesis genes were dysregulated, and morphol-
ogy and function also deteriorated in a-MHC CaMKKbkd TG
mice compared with WT mice after TAC. It is known that PGC-
1a is abundantly expressed in the heart and a number of gain-of-
function and loss-of-function assays have shown that PGC-1a
activates most genes of mitochondrial biology and stimulates both
fatty acid oxidation and oxidative respiration in cardiac tissues
[28,29,30,31,32]. The decrease in PGC-1a expression and
mitochondrial morphological changes would be another reason
for the reduction in energy pooling in the left ventricle of a-MHC
CaMKKbkd TG mice. These data indicate the vital role that
PGC-1a plays in maintaining normal cardiac energetics and
contractile function, especially in response to physiological stimuli.
Our data clearly indicate that CaMKKb exerts beneficial effects
against pressure-overload-induced heart failure. It is important to
note, however, that massive induction of PGC-1a in the heart
increased mitochondrial content to such an extent that myofibrils
were displaced and resulted in cardiomyopathy [28,31]. Hence, it
may be necessary to increase CaMKKb activity in an appropriate
and moderate fashion for the treatment of heart failure.
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